a pharmaceutical composition and an agent that can be used for treatment of epidurally migrating herniated intervertebral disc are provided . the composition comprises a glycosaminoglycan degrading enzyme , preferably chondroitinase , more preferably chondroitinase abc , in an amount effective to dissolve nucleus pulposus epidurally existing .